<code id='720DA162E4'></code><style id='720DA162E4'></style>
    • <acronym id='720DA162E4'></acronym>
      <center id='720DA162E4'><center id='720DA162E4'><tfoot id='720DA162E4'></tfoot></center><abbr id='720DA162E4'><dir id='720DA162E4'><tfoot id='720DA162E4'></tfoot><noframes id='720DA162E4'>

    • <optgroup id='720DA162E4'><strike id='720DA162E4'><sup id='720DA162E4'></sup></strike><code id='720DA162E4'></code></optgroup>
        1. <b id='720DA162E4'><label id='720DA162E4'><select id='720DA162E4'><dt id='720DA162E4'><span id='720DA162E4'></span></dt></select></label></b><u id='720DA162E4'></u>
          <i id='720DA162E4'><strike id='720DA162E4'><tt id='720DA162E4'><pre id='720DA162E4'></pre></tt></strike></i>

          hotspot

          hotspot

          author:fashion    Page View:967
          J.P. Morgan office building at night -- JPM health business coverage from STAT
          Adobe

          SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so. 

          Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P. Morgan Healthcare Conference, asking them for interviews. For the uninitiated, it’s usually the other way around.

          advertisement

          Their message? We’re still here. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Intellia reports positive results for its CRISPR
          Intellia reports positive results for its CRISPR

          RubyWallauforSTATIntelliaTherapeuticssaidSundaythatthefirst10patientstoreceiveaCRISPR-basedtreatment

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Innovation in antibiotics is ailing. 'Brain drain' may kill it

          Asantibioticsresearchshrivels,thebraindrainawayfromthisfieldwillhavemanylabslookingthisempty.AdobeIn